November 28, 2017
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Study finds most adjunctive glaucoma therapies used only twice a day
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Savak “Sev” Teymoorian, MD, MBA, discusses a survey of adjunctive glaucoma therapy prescribing by ophthalmologists that shows the majority prescribe twice a day as opposed to the labeled three times daily treatment. The study found adherence and patient quality of life were the main factors.